Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
[Nurse practitioners as key actors in pulmonary rehabilitation for chronic obstructive pulmonary disease].
Revue des maladies respiratoires·2022
Same author
Severe forms of COVID-19 among patients with chronic respiratory diseases: be attentive to the severity of the underlying respiratory impairment.
Respiratory medicine and research·2022
Same author
[The role of cardiac magnetic resonance imaging in pulmonary arterial hypertension and chronic thrombo-embolic pulmonary hypertension].
Revue des maladies respiratoires·2022
Same author
[Specific effect of exercise training on depression in COPD patients].
Revue des maladies respiratoires·2021
Same author
[IgG4-Related Disease: A rare cause of severe interstitial lung disease].
Revue des maladies respiratoires·2021
Same author
[Familial pulmonary veno-occlusive disease with a composite biallelic heterozygous EIF2AK4 mutation].
Revue des maladies respiratoires·2020
Same journal
[French version of the guidelines for connective tissue disease-associated ILD].
Revue des maladies respiratoires·2026
Same journal
[Pulmonary expression of an asymptomatic lysosomal storage disorder].
Revue des maladies respiratoires·2026
Same journal
[Factors associated with FEV1 evolution in cystic fibrosis patients treated by CFTR modulator tritherapy].
Revue des maladies respiratoires·2026
Same journal
[Subacute pulmonary coccidioidomycosis: A differential diagnosis of lung cancer].
Revue des maladies respiratoires·2026
Same journal
[Relevance of the ACT score in severe asthma with obesity: A pilot study].
Revue des maladies respiratoires·2026
Same journal
[Automated analysis of mandibular movements for the screening of obstructive sleep apnea].
Revue des maladies respiratoires·2026
Related Experiment Video
Updated: Jun 17, 2026
09:22
Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
[Chronic cor pulmonale in COPD]
1Service des Maladies Respiratoires et de Réanimation Respiratoire, Hôpital de Brabois, CHU de Nancy, France.
Revue Des Maladies Respiratoires
|December 25, 2009
Summary
No abstract available in PubMed .
